This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Aug 1;28(22):3545-8.

doi: 10.1200/JCO.2010.28.5791. Epub 2010 Jun 14.

Personalizing therapy for ovarian cancer: BRCAness and beyond

Robert C Bast Jr, Gordon B Mills

PMID: 20547987
DOI: 10.1200/JCO.2010.28.5791

Editorial

Personalizing therapy for ovarian cancer: BRCAness and beyond

Robert C Bast Jr et al. J Clin Oncol. 2010.

. 2010 Aug 1;28(22):3545-8.

doi: 10.1200/JCO.2010.28.5791. Epub 2010 Jun 14.

Authors

Robert C Bast Jr, Gordon B Mills

PMID: 20547987
DOI: 10.1200/JCO.2010.28.5791

No abstract available

PubMed Disclaimer

Comment on

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
Konstantinopoulos PA, Spentzos D, Karlan BY, Taniguchi T, Fountzilas E, Francoeur N, Levine DA, Cannistra SA. Konstantinopoulos PA, et al. J Clin Oncol. 2010 Aug 1;28(22):3555-61. doi: 10.1200/JCO.2009.27.5719. Epub 2010 Jun 14. J Clin Oncol. 2010. PMID: 20547991 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

P50 CA098258/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information